NM_198994.3:c.1550T>G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 1P and 3B. PP3BP4BP6BS2_Supporting

The NM_198994.3(TGM6):​c.1550T>G​(p.Leu517Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000329 in 1,612,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000030 ( 0 hom. )

Consequence

TGM6
NM_198994.3 missense

Scores

5
10
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:1B:2

Conservation

PhyloP100: 4.58

Publications

17 publications found
Variant links:
Genes affected
TGM6 (HGNC:16255): (transglutaminase 6) The protein encoded by this gene belongs to the transglutaminase superfamily. It catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins. Mutations in this gene are associated with spinocerebellar ataxia type 35 (SCA35). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
TGM6 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 35
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, Cadd, MutationAssessor, PROVEAN, REVEL, REVEL [when Dann, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.27106234).
BP6
Variant 20-2417445-T-G is Benign according to our data. Variant chr20-2417445-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 31085.
BS2
High AC in GnomAd4 at 9 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGM6NM_198994.3 linkc.1550T>G p.Leu517Trp missense_variant Exon 10 of 13 ENST00000202625.7 NP_945345.2 O95932-1
TGM6NM_001254734.2 linkc.1550T>G p.Leu517Trp missense_variant Exon 10 of 12 NP_001241663.1 O95932-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGM6ENST00000202625.7 linkc.1550T>G p.Leu517Trp missense_variant Exon 10 of 13 1 NM_198994.3 ENSP00000202625.2 O95932-1
TGM6ENST00000381423.1 linkc.1550T>G p.Leu517Trp missense_variant Exon 10 of 12 1 ENSP00000370831.1 O95932-2

Frequencies

GnomAD3 genomes
AF:
0.0000591
AC:
9
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000153
AC:
38
AN:
248278
AF XY:
0.000149
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00202
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.0000301
AC:
44
AN:
1460000
Hom.:
0
Cov.:
33
AF XY:
0.0000289
AC XY:
21
AN XY:
726356
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00101
AC:
40
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86228
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111962
Other (OTH)
AF:
0.0000662
AC:
4
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000591
AC:
9
AN:
152302
Hom.:
0
Cov.:
32
AF XY:
0.0000806
AC XY:
6
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41580
American (AMR)
AF:
0.00
AC:
0
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00173
AC:
9
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67992
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000803
Hom.:
0
Bravo
AF:
0.0000453
ExAC
AF:
0.000107
AC:
13

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Spinocerebellar ataxia type 35 Pathogenic:2Uncertain:1
Feb 28, 2019
Codex Genetics Limited
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:provider interpretation

- -

Dec 01, 2010
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

May 28, 2019
Mendelics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Acute myeloid leukemia Pathogenic:1
-
Fujian Institute of Hematology, Fujian Medical University
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not specified Benign:1
Oct 16, 2023
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 26, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Uncertain
0.020
T
BayesDel_noAF
Pathogenic
0.25
CADD
Pathogenic
27
DANN
Benign
0.96
DEOGEN2
Benign
0.23
T;.
Eigen
Uncertain
0.68
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.87
D;D
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.27
T;T
MetaSVM
Uncertain
0.40
D
MutationAssessor
Pathogenic
3.0
M;M
PhyloP100
4.6
PrimateAI
Uncertain
0.51
T
PROVEAN
Pathogenic
-4.6
D;D
REVEL
Pathogenic
0.68
Sift
Uncertain
0.0020
D;D
Sift4G
Uncertain
0.0050
D;D
Polyphen
1.0
D;D
Vest4
0.77
MutPred
0.64
Gain of catalytic residue at L515 (P = 0.0025);Gain of catalytic residue at L515 (P = 0.0025);
MVP
0.57
MPC
0.58
ClinPred
0.31
T
GERP RS
4.7
Varity_R
0.88
gMVP
0.73
Mutation Taster
=22/78
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs387907097; hg19: chr20-2398091; API